Published in Arch Dis Child on July 18, 2007
Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet (2011) 5.42
Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J (2012) 1.96
Inhaled corticosteroids in lung diseases. Am J Respir Crit Care Med (2013) 0.91
Pharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues. Front Pharmacol (2011) 0.79
The effects of inhaled corticosteroids on growth in children. Open Respir Med J (2014) 0.79
Does Use of Inhaled Corticosteroid for Management of Asthma in Children Make Them Shorter Adults? Pediatr Allergy Immunol Pulmonol (2013) 0.75
Do the benefits of daily inhaled steroid treatment of mild asthma outweigh the risks? Arch Dis Child (2008) 0.75
Revisiting early intervention in adult asthma. ERJ Open Res (2015) 0.75
Regular use of inhaled corticosteroids controls symptoms of mild persistent asthma, but with growth effect. J Pediatr (2009) 0.75
Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med (1995) 33.41
Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med (2000) 8.32
Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med (2005) 7.61
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet (2003) 5.10
Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med (1994) 4.76
Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child (2002) 3.35
A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med (1997) 3.19
Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med (2000) 2.89
Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP) J Allergy Clin Immunol (1999) 2.35
Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest (1995) 2.06
Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med (1994) 2.02
Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med (1995) 1.96
Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis (1992) 1.89
Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest (2006) 1.85
High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children. Cochrane Database Syst Rev (2004) 1.79
Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. European Respiratory Society. Eur Respir J (1997) 1.50
Bronchial lability and responsiveness in school children born very preterm. Am J Respir Crit Care Med (1997) 1.33
Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group. Am Rev Respir Dis (1993) 1.24
Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol (1998) 1.24
A novel format for a growth chart. Acta Paediatr Scand (1984) 1.22
Natural history of allergic diseases in children. Acta Paediatr Scand (1990) 1.08
One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height. Am J Respir Crit Care Med (2001) 1.00
A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07
Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med (1994) 4.76
Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis (1985) 4.59
Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med (1991) 4.09
Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ (1996) 3.79
No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy (2002) 2.99
The Brussels Declaration: the need for change in asthma management. Eur Respir J (2008) 2.91
Dampness in buildings and health. Nordic interdisciplinary review of the scientific evidence on associations between exposure to "dampness" in buildings and health effects (NORDDAMP). Indoor Air (2001) 2.71
Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol (1992) 2.16
Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet (1993) 1.98
Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax (2003) 1.94
School as a risk environment for children allergic to cats and a site for transfer of cat allergen to homes. J Allergy Clin Immunol (1999) 1.83
Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy (2002) 1.82
Reference values for lung function tests in men: regression equations with smoking variables. Ups J Med Sci (1986) 1.77
Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy (2005) 1.75
Reference values for lung function tests in females. Regression equations with smoking variables. Bull Eur Physiopathol Respir (1986) 1.74
Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis (1993) 1.73
GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy (2009) 1.72
Incidence of occupational asthma and persistent asthma in young adults has increased in Finland. Chest (1996) 1.61
Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper type 1 response? Am J Respir Cell Mol Biol (2000) 1.61
Increase of allergen-specific immunoglobulin E antibodies from 1973 to 1994 in a Finnish population and a possible relationship to Helicobacter pylori infections. Clin Exp Allergy (2002) 1.59
High prevalence of asthma in cross country skiers. BMJ (1993) 1.56
Nutritional modulation of exercise-induced immunodepression in athletes: a systematic review and meta-analysis. Eur J Clin Nutr (2006) 1.51
GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy (2009) 1.51
Cow's milk allergy as a predictor of bronchial hyperresponsiveness and airway inflammation at school age. Clin Exp Allergy (2010) 1.50
Acute childhood asthma in Finland: a retrospective review of hospital admissions from 1976 to 1995. Pediatr Allergy Immunol (2000) 1.50
Exposure to bacteria in swine-house dust and acute inflammatory reactions in humans. Am J Respir Crit Care Med (1996) 1.46
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45
The GINA Asthma Challenge: reducing asthma hospitalisations. Eur Respir J (2011) 1.45
Impact of occupation on respiratory disease. Scand J Work Environ Health (2000) 1.45
Asthma and atopy - the price of affluence? Allergy (2004) 1.45
Is atopy a risk factor for the use of contact lenses? Allergy (1992) 1.44
Dampness in buildings as a risk factor for health effects, EUROEXPO: a multidisciplinary review of the literature (1998-2000) on dampness and mite exposure in buildings and health effects. Indoor Air (2004) 1.44
Can early asthma be confirmed by laboratory tests? Allergy (1996) 1.42
Collection of airborne micro-organisms on Nuclepore filters, estimation and analysis--CAMNEA method. J Appl Bacteriol (1986) 1.39
Randomised comparison of cost effectiveness of guided self management and traditional treatment of asthma in Finland. BMJ (1998) 1.38
A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population. Nat Genet (2001) 1.36
Worsening of asthma in children allergic to cats, after indirect exposure to cat at school. Am J Respir Crit Care Med (2001) 1.36
Inhalation of swine dust induces cytokine release in the upper and lower airways. Eur Respir J (1997) 1.34
The South Karelia Air Pollution Study. The effects of malodorous sulfur compounds from pulp mills on respiratory and other symptoms. Am Rev Respir Dis (1990) 1.34
Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler. Allergy (1989) 1.31
Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: A prospective study of 6209 infants. J Allergy Clin Immunol (1999) 1.28
Induction of IL-8 production in human alveolar macrophages and human bronchial epithelial cells in vitro by swine dust. Thorax (1998) 1.26
Standard skin prick testing and sensitization to inhalant allergens across Europe--a survey from the GALEN network. Allergy (2005) 1.25
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy (2011) 1.22
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'. Allergy (2009) 1.22
A novel format for a growth chart. Acta Paediatr Scand (1984) 1.22
Reduction of asthma burden is possible through National Asthma Plans. Allergy (2010) 1.21
Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol (2000) 1.18
Asthma and increased bronchial responsiveness in elite athletes: atopy and sport event as risk factors. J Allergy Clin Immunol (1998) 1.17
Allergy and asthma in elite summer sport athletes. J Allergy Clin Immunol (2000) 1.17
Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler). Eur Respir J (1990) 1.16
Intense physical training decreases circulating antioxidants and endothelium-dependent vasodilatation in vivo. Atherosclerosis (1999) 1.16
Mycotoxins in crude building materials from water-damaged buildings. Appl Environ Microbiol (2000) 1.13
Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy (2008) 1.10
Time course of interleukin-6 and tumor necrosis factor-alpha increase in serum following inhalation of swine dust. Am J Respir Crit Care Med (1996) 1.09
Adaptive Aerosol Delivery (AAD) technology. Expert Opin Drug Deliv (2004) 1.07
Immunoglobulin E specific to wheat and rye flour proteins. Clin Allergy (1977) 1.06
Bronchial asthma and hyperreactivity after early childhood bronchiolitis or pneumonia. An 8-year follow-up study. Arch Pediatr Adolesc Med (1994) 1.06
Effect of epidural versus general anaesthesia on calf blood flow. Acta Anaesthesiol Scand (1980) 1.05
Airway inflammation in patients with symptoms suggesting asthma but with normal lung function. Eur Respir J (2000) 1.04
Determinants of respiratory system input impedance and bronchodilator response in healthy Finnish preschool children. Clin Physiol Funct Imaging (2002) 1.04
How much nebulised budesonide reaches infants and toddlers? Arch Dis Child (1992) 1.03
Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values. Pediatr Pulmonol (2006) 1.03
Reproducibility of home spirometry in children with newly diagnosed asthma. Pediatr Pulmonol (2000) 1.03
GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. Allergy (2009) 1.03
Signs of reversing trends in prevalence of asthma. Allergy (2005) 1.03
Degree and clinical relevance of sensitization to common allergens among adults: a population study in Helsinki, Finland. Clin Exp Allergy (2006) 1.03
Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension. Arch Dis Child (1993) 1.02
Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen. Br J Sports Med (1998) 1.02
Exposure-response relationships for work-related sensitization in workers exposed to rat urinary allergens: results from a pooled study. J Allergy Clin Immunol (1999) 1.02
Gram positive bacteria induce IL-6 and IL-8 production in human alveolar macrophages and epithelial cells. Inflammation (1999) 1.01
Exposure to hydrogen sulphide and respiratory function. Br J Ind Med (1990) 1.01
Endotoxin levels in farming: absence of symptoms despite high exposure levels. Br J Ind Med (1989) 1.00
Weight loss interventions in asthma: EAACI evidence-based clinical practice guideline (part I). Allergy (2013) 0.99
Asthma, lung function, and bronchial responsiveness in welders. Am J Ind Med (1994) 0.99
Asthma, allergic rhinitis and atopic eczema in Finnish children and adolescents. Allergy (1991) 0.99
Allergy gap between Finnish and Russian Karelia on increase. Allergy (2011) 0.99
Swine dust induces cytokine secretion from human epithelial cells and alveolar macrophages. Clin Exp Immunol (1999) 0.98
Association between type of training and risk of asthma in elite athletes. Thorax (1997) 0.98
Hypersensitivity reactions to food additives. Allergy (1987) 0.98
Prospective study of laboratory-animal allergy: factors predisposing to sensitization and development of allergic symptoms. Allergy (1994) 0.97
Farmer's lung--a 5-year follow-up of eighty-six patients. Clin Allergy (1987) 0.97
Adherence to the Mediterranean diet and fresh fruit intake are associated with improved asthma control. Allergy (2008) 0.96
Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid. Am Rev Respir Dis (1991) 0.96
Real-world clinical data identifies gender-related profiles in chronic obstructive pulmonary disease. COPD (2009) 0.96
Allergic disorders and immediate skin test reactivity in Finnish adolescents. Allergy (1980) 0.96
Alterations in bronchoalveolar lavage fluid but not in lung function and bronchial responsiveness in swine confinement workers. Chest (1992) 0.96
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
Mechanisms of asthma in Olympic athletes--practical implications. Allergy (2008) 0.95
Exposure to microorganisms, febrile and airway-obstructive symptoms, immune status and lung function of Swedish farmers. Scand J Work Environ Health (1985) 0.95